Page last updated: 2024-08-24

naphthalimides and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

naphthalimides has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, F; Chen, Z; Hu, Y; Liu, Y; Wang, J; Wu, S; Xue, J; Yang, F; Yang, Y; Zheng, M; Zhou, X; Zhu, H1

Other Studies

1 other study(ies) available for naphthalimides and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

ArticleYear
MEAN inhibits hepatitis C virus replication by interfering with a polypyrimidine tract-binding protein.
    Journal of cellular and molecular medicine, 2016, Volume: 20, Issue:7

    Topics: Antiviral Agents; Cell Death; Cell Line, Tumor; Cytoplasm; Down-Regulation; Drug Synergism; Gene Knockdown Techniques; Green Fluorescent Proteins; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Internal Ribosome Entry Sites; Mutant Proteins; Naphthalimides; Phenylenediamines; Polypyrimidine Tract-Binding Protein; Protein Biosynthesis; Protein Transport; Ribavirin; RNA, Messenger; RNA, Small Interfering; RNA, Viral; Sulfonamides; Virus Replication

2016